Matinas BioPharma Holdings Inc (MTNB)
0.5799
+0.04
(+7.39%)
USD |
NYAM |
Nov 21, 16:00
0.56
-0.02
(-3.43%)
Pre-Market: 20:00
Matinas BioPharma Holdings Enterprise Value: -7.845M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | -7.845M |
| November 20, 2024 | -8.048M |
| November 19, 2024 | -7.921M |
| November 18, 2024 | -7.687M |
| November 15, 2024 | -7.641M |
| November 14, 2024 | -7.568M |
| November 13, 2024 | -7.183M |
| November 12, 2024 | -7.000M |
| November 11, 2024 | -6.217M |
| November 08, 2024 | -7.256M |
| November 07, 2024 | -7.972M |
| November 06, 2024 | -8.099M |
| November 05, 2024 | -7.997M |
| November 04, 2024 | -7.909M |
| November 01, 2024 | -7.835M |
| October 31, 2024 | -7.641M |
| October 30, 2024 | -0.9771M |
| October 29, 2024 | 3.398M |
| October 28, 2024 | 5.483M |
| October 25, 2024 | 5.738M |
| October 24, 2024 | 5.534M |
| October 23, 2024 | 6.297M |
| October 22, 2024 | 8.129M |
| October 21, 2024 | 8.180M |
| October 18, 2024 | 10.16M |
| Date | Value |
|---|---|
| October 17, 2024 | 9.96M |
| October 16, 2024 | 8.993M |
| October 15, 2024 | 6.908M |
| October 14, 2024 | 5.331M |
| October 11, 2024 | 5.382M |
| October 10, 2024 | 5.534M |
| October 09, 2024 | 5.336M |
| October 08, 2024 | 5.941M |
| October 07, 2024 | 5.636M |
| October 04, 2024 | 4.491M |
| October 03, 2024 | 4.212M |
| October 02, 2024 | 4.822M |
| October 01, 2024 | 6.552M |
| September 30, 2024 | 7.213M |
| September 27, 2024 | 3.595M |
| September 26, 2024 | 3.595M |
| September 25, 2024 | 3.946M |
| September 24, 2024 | 3.645M |
| September 23, 2024 | 4.147M |
| September 20, 2024 | 4.197M |
| September 19, 2024 | 4.598M |
| September 18, 2024 | 3.344M |
| September 17, 2024 | 3.706M |
| September 16, 2024 | 4.298M |
| September 13, 2024 | 4.950M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.099M
Minimum
Nov 06 2024
353.10M
Maximum
Jan 02 2020
101.23M
Average
99.26M
Median
May 16 2022
Enterprise Value Benchmarks
| Equillium Inc | -0.3668M |
| Tenon Medical Inc | 2.839M |
| Alphatec Holdings Inc | 1.894B |
| Merck & Co Inc | 276.21B |
| Madrigal Pharmaceuticals Inc | 6.299B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.275M |
| Total Expenses (Quarterly) | 4.381M |
| EPS Diluted (Quarterly) | -0.85 |
| Earnings Yield | -826.0% |
| Normalized Earnings Yield | -1018.29 |